Inside Helicore Biopharma’s obesity therapeutics patent portfolio
Highlights: Helicore Biopharma has emerged as a notable player in obesity therapeutics research through its work on neutralizing the glucose-dependent insulinotropic polypeptide, or GIP. Backed...








